$MRK Headlines Why the M&A outbreak hurts Big Pharma

New Post Public Reply Private Reply Replies (0) Message Board

Feb 8, 2015 at 10:54 AM

$MRK Headlines

Why the M&A outbreak hurts Big Pharma 10:30 a.m. Feb. 5, 2015 - David Weidner
Keurig Green Mountain burned by weak outlook, sales 6:35 p.m. Feb. 4, 2015 - Sue Chang
U.S. stocks end lower as ECB reject Greek bonds as collateral 4:33 p.m. Feb. 4, 2015 - Barbara Kollmeyer
Gilead to discount its pricey Sovaldi drug 1:55 p.m. Feb. 4, 2015 - Russ Britt
Careful what you wish for: Oil-price recovery may sting 8:28 a.m. Feb. 4, 2015 - Shawn Langlois
Merck sales fall amid headwinds 7:24 a.m. Feb. 4, 2015 - MarketWatch.com
Merck's stock falls 1.7% after earnings 7:16 a.m. Feb. 4, 2015 - Silvia Ascarelli
Merck sees 2015 sales of $38.3 bln to $39.8 bln 7:15 a.m. Feb. 4, 2015 - Silvia Ascarelli
Merck expects 2015 EPS $1.62-$1.91, adj. EPS of $3.32-$3.47 7:13 a.m. Feb. 4, 2015 - Silvia Ascarelli
Merck Q4 revenue falls 7% to $10.48 bln from $11.32 bln 7:12 a.m. Feb. 4, 2015 - Silvia Ascarelli
Merck reports Q4 EPS of $2.54, adj. EPS of $0.87 7:11 a.m. Feb. 4, 2015 - Silvia Ascarelli
What to look for in Merck earnings 11:41 a.m. Feb. 2, 2015 - Peter Loftus
Gasoline ‘tax cut’ in focus on energy, consumer-based earnings 6:13 a.m. Feb. 2, 2015 - Wallace Witkowski
Does Jersey’s lagging economy doom Christie’s bid? 8:31 a.m. Jan. 26, 2015 - Tim Mullaney
How you can cash in on the dollar’s coming decline 6:01 a.m. Jan. 22, 2015 - Michael Brush
Don’t look for pricey hepatitis drugs to come down 2:32 p.m. Jan. 13, 2015 - Russ Britt
Three investments to own and three to 6:00 a.m. Jan. 13, 2015 - Howard Gold
Bristol-Myers Squibb jumps on Opdivo cancer drug test 8:17 a.m. Jan. 12, 2015 - Angela Chen
Here are the best-performing stocks so far in 2015 11:47 a.m. Jan. 9, 2015 - Philip van Doorn
Ebola vaccines ready for West Africa tests: WHO 11:11 a.m. Jan. 9, 2015 - MarketWatch.com

In Perspective: The Ridiculously Large Market Caps Of America's 20 Most Valuable Companies 21 min ago - Seeking Alpha
Week In Review: WuXi NextCode Leads $15 Million Financing In Claritas Genomics 4:46 a.m. Today - Seeking Alpha
AbbVie: Big Pharma at a Discount Price 4:24 a.m. Feb. 7, 2015 - Barrons.com
Gilead’s Dividend Debut; GM Relents 9:38 p.m. Feb. 6, 2015 - Barrons.com
Seeking Alpha's Biotech Weekly: Questioning Gilead, MannKind To Market, And More 4:00 p.m. Feb. 6, 2015 - Seeking Alpha
Dow 30 Stock Roundup: Disney, Exxon Beat, United Technologies Raises Dividend - Analyst Blog 2:15 p.m. Feb. 6, 2015 - Zacks.com
Gabelli's Q4 Picks Include Acquisition Targets 9:44 a.m. Feb. 6, 2015 - GuruFocus.com
Merck prices debt offering 7:04 a.m. Feb. 6, 2015 - Seeking Alpha
Biotech Stock Mailbag: Hep C stocks, Bluebird, Advaxis, Hemispherx 6:05 a.m. Feb. 6, 2015 - TheStreet.com
U.S. Stocks Post Big Rebound This Week, Still Best Investment 3:56 p.m. Feb. 5, 2015 - TheStreet.com
Dow Jones (DJIA) Today: Merck (MRK) Lower 2:00 p.m. Feb. 5, 2015 - TheStreet.com
Big Pharma Weak Guidance Put These ETFs in Focus - ETF News And Commentary 11:00 a.m. Feb. 5, 2015 - Zacks.com
Gilead Sciences Falls 10% After More Than Doubling Drug Discounts For 2015 10:35 a.m. Feb. 5, 2015 - GuruFocus.com
The Reasons That Make Pfizer A Worthy Hold. 10:19 a.m. Feb. 5, 2015 - GuruFocus.com
Company News for February 05, 2015 - Corporate Summary 10:10 a.m. Feb. 5, 2015 - Zacks.com
Large Cap Pharmaceutical Stocks to Buy Despite Negative Pricing Headlines 9:31 a.m. Feb. 5, 2015 - 247WallSt.com
Mixed Signals, Extreme Volatility Plague Market 8:04 p.m. Feb. 4, 2015 - InvestorPlace.com
Stocks Falter After ECB Move 4:52 p.m. Feb. 4, 2015 - The Wall Street Journal Interactive Edition
Merck Sales Fall on Stronger Dollar, Patent Expirations 2:21 p.m. Feb. 4, 2015 - The Wall Street Journal Interactive Edition
HCV Stocks Struggle As Gilead, Merck Face Headwinds 11:12 a.m. Feb. 4, 2015 - Investors Business Daily

Fitch Rates Merck's Debt Offering 'A+'; Outlook Negative 1:07 p.m. Feb. 6, 2015 - BusinessWire - BZX
Merck Prices $8.0 Billion Debt Offering 7:37 p.m. Feb. 5, 2015 - BusinessWire - BZX
World Membrane Separation Technologies Industry, Global Industry Analysts 2:28 p.m. Feb. 5, 2015 - PR Newswire - PRF
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany 2:32 p.m. Feb. 3, 2015 - PR Newswire - PRF
Merck’s Insomnia Medicine BELSOMRA® (suvorexant) C-IV, the First and Only Orexin Receptor Antagonist, Now Available in the United States 8:00 a.m. Feb. 3, 2015 - BusinessWire - BZX
Merck's Insomnia Medicine BELSOMRA® (suvorexant) C-IV, the First and Only Orexin Receptor Antagonist, Now Available in the United States 8:00 a.m. Feb. 3, 2015 - PR Newswire - PRF
Technical Commentary on Pharma Stocks -- Merck, AbbVie, Bristol-Myers Squibb, Shire, and Mallinckrodt 8:45 a.m. Jan. 30, 2015 - PR Newswire - PRF
Hortonworks Establishes Data Governance Initiative 9:00 a.m. Jan. 28, 2015 - PR Newswire - PRF
Global Pediatric Drugs and Vaccines Market 11:56 a.m. Jan. 27, 2015 - PR Newswire - PRF
TransCelerate BioPharma Welcomes Merck & Co. and Novo Nordisk to its Membership Roster 11:25 a.m. Jan. 27, 2015 - BusinessWire - BZX
TransCelerate BioPharma Welcomes Merck & Co. and Novo Nordisk to its Membership Roster 10:00 a.m. Jan. 27, 2015 - BusinessWire - BZX
Euclises Announces Appointment of Bobby Sandage as New CEO 8:00 a.m. Jan. 27, 2015 - BusinessWire - BZX
Sickle-cell Anemia Therapeutics Market in the US 2015-2019 12:33 p.m. Jan. 26, 2015 - PR Newswire - PRF
Merck Announces CHMP Issues Positive Opinion for Investigational Antibiotic SIVEXTRO® (tedizolid phosphate) 8:30 a.m. Jan. 26, 2015 - BusinessWire - BZX
Merck, on Behalf of its Wholly Owned Subsidiary, Cubist Pharmaceuticals, Announces Tender Offer for Cubist’s 2.50% Convertible Senior Notes Due 2017, 1.125% Convertible Senior Notes due 2018 and 1.875% Convertible Senior Notes due 2020 3:29 p.m. Jan. 22, 2015 - BusinessWire - BZX
Eleven Biotherapeutics Appoints Barry Gertz, MD, PhD, and Jay S. Duker, MD, to Board of Directors 8:01 a.m. Jan. 22, 2015 - BusinessWire - BZX
Merck Completes Tender Offer to Acquire Cubist 8:03 a.m. Jan. 21, 2015 - BusinessWire - BZX
Dana Holding Set to Join the S&P MidCap 400 5:45 p.m. Jan. 20, 2015 - PR Newswire - PRF
Vaccine Manufacturing Technology and Services: World Market Forecast 2014-2024 10:36 a.m. Jan. 15, 2015 - PR Newswire - PRF
Insider Trading Alerts for Google, Oasis Petroleum, Best Buy, Twitter, Merck, and First Niagara Financial Group 8:45 a.m. Jan. 15, 2015 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Howard Hughes Joins S&P SmallCap 600, Arcosa Out

Shakeup in the S&P SmallCap 600 It’s one of those days where something shifts in the market landscape—Howard Hughes Holdings Inc. (NYSE: HHH) is swaggering into the S&P SmallCap 600. Kicking off on October 28, it's got quite the entrance lined up. On the other end, Arcosa Inc. (NYSE: ACA) is making a hasty exit after getting scooped up by CRH plc (NYSE: CRH). For...

Amy Johnson Steps Up as GDIT President Amid Shifts

A New Chapter for GDIT with a Veteran Leader Big shoes to fill? Nah, more like Amy Johnson was made for these shoes. Stepping up as president of General Dynamics Information Technology (GDIT) on November 3, she’s got 27 years of experience under her belt, all from General Dynamics' own backyard. This ain't her first rodeo. From tightrope-walking the perils of defense...

Boots Group Wraps Up Consent Solicitation for Notes

Consent Solicitation's Critical Role in Acquisition No time for dawdling—Boots Group's gathered up their consent cards for hefty senior secured notes, and we're talking close to a billion smackers here. It's a bold move to grease the wheels on looming acquisition maneuvers. We're looking at a €650 million and a £375 million stack of senior secured notes patiently...

Stephen A. Smith Calls for Corporate Support of HBCUs

A Stand for Education at the White House Stephen A. Smith stirred the pot with his decision to attend a White House dinner, a move that had tongues wagging across the media landscape. But this time, it wasn't about the usual hustle and bustle of the sports world. Smith had his sights set on the big picture, specifically, the long-term financial stability of Historically...

Divorce Expertise: Obenhaus Adds CDFA Credential

Divorce isn't just a legal tangled mess; it's a financial minefield as well. Lindsey Obenhaus from Goranson Bain Ausley has beefed up her credentials with a Certified Divorce Financial Analyst® (CDFA®) designation, lending a sharper edge to her approach in divorce financials. When relationships turn sour, so do wallets, and Obenhaus aims to soften that blow for her...

Unicoin’s 'RISE IN PINK' Blends Crypto and Charity

The New Face of Charitable Giving: Crypto and Cause Turning the spotlight on how blockchain and altruism can mesh, Unicoin's latest campaign isn’t just your average philanthropic endeavor. With 'RISE IN PINK', they're out to change the game, blending digital assets with a deep human cause—breast cancer awareness and support. Technology Meets Human Cause Imagine...

Bimbo Bakeries Teamsters Avert Strike in Chicago

Teamsters Flex Muscle in Bakery Dispute Sometimes, it's a matter of holding your ground until the last minute. That’s exactly the brand of guts the workers at Bimbo Bakeries in Chicago just displayed, securing a robust agreement mere hours before hitting the picket line. These 275 warehouse and route sales folks threw down the gauntlet with management and,...

Baidu Faces Securities Fraud Lawsuit: Key Investor Alert

Stormy Weather for Baidu Investors Digging through the latest on Baidu's (NASDAQ:BIDU) unsettling journey feels like watching a rerun of a soap opera you wish would just end. The company has been slapped with a class action lawsuit by The Law Offices of Frank R. Cruz, accusing them of pulling the wool over investors' eyes from November 18, 2025, to August 17, 2026....

Veterans Find Community and Wellness at Orland Hills Bash

A Celebration of Veterans and Community Orland Hills is set to light up with a unique Veterans Day Bash on November 1, 2026. This isn't just your run-of-the-mill community gathering; it's an event that brings together veterans from all around for a day packed with resources, education, and a chance to connect with kindred spirits—all thanks to the collaboration between...

Quest Diagnostics Faces Class Action After Data Breach

Data Breach Rocks Quest Diagnostics October 2026 caught Quest Diagnostics in a bind they wish they could escape—a classic tech breach with personal info hanging out to dry. When a cyber ghost slipped into Quest's Quanum Lab Services Manager, it wasn't to deliver flowers. Nope, this unauthorized access was no friendly visit, forcing Quest to scream foul and play serious...